KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Current Taxes (2016 - 2018)

Idexx Laboratories has reported Current Taxes over the past 9 years, most recently at $26.5 million for Q1 2018.

  • Quarterly results put Current Taxes at $26.5 million for Q1 2018, up 24.35% from a year ago — trailing twelve months through Mar 2018 was $26.5 million (up 24.35% YoY), and the annual figure for FY2017 was $29.4 million, up 22.59%.
  • Current Taxes for Q1 2018 was $26.5 million at Idexx Laboratories, down from $29.4 million in the prior quarter.
  • Over the last five years, Current Taxes for IDXX hit a ceiling of $29.4 million in Q1 2015 and a floor of $15.4 million in Q1 2014.
  • Median Current Taxes over the past 5 years was $24.0 million (2016), compared with a mean of $23.2 million.
  • Peak annual rise in Current Taxes hit 91.24% in 2015, while the deepest fall reached 33.32% in 2015.
  • Idexx Laboratories' Current Taxes stood at $28.4 million in 2014, then crashed by 33.32% to $19.0 million in 2015, then grew by 26.42% to $24.0 million in 2016, then increased by 22.59% to $29.4 million in 2017, then dropped by 9.99% to $26.5 million in 2018.
  • The last three reported values for Current Taxes were $26.5 million (Q1 2018), $29.4 million (Q4 2017), and $24.9 million (Q3 2017) per Business Quant data.